Fresenius Kabi Reveals €800m Biopharma Ambitions By 2026

German Firm Also Raises Its Revenue, Margin Guidance For 2023

 
• By Dean Rudge
  
Ambition concept with businessman climbing stairs
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products